AI Model "RiboNN" Accelerates Discovery of mRNA Vaccines and Therapies
In a major scientific breakthrough, researchers have developed an AI that can predict how efficiently mRNA sequences produce proteins, speeding up the search for new treatments for viruses, cancers, and genetic disorders.
"RiboNN" AI Promises to Revolutionize mRNA Drug Discovery
A major scientific breakthrough announced on July 25 could dramatically accelerate the development of next-generation vaccines and therapies. Researchers from the University of Texas at Austin and the pharmaceutical company Sanofi have detailed a new AI model called RiboNN that can predict how efficiently specific mRNA sequences will produce proteins.
Cracking a Key Biological Code
The discovery of new mRNA-based drugs—for everything from viruses and cancers to rare genetic disorders—depends on a critical, but often slow, process of finding the right mRNA sequence to generate a therapeutic protein. RiboNN addresses …
Archive Access
This article is older than 24 hours. Create a free account to access our 7-day archive.